STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi
PR Newswire —
European Commission grants approval for Gotenfia®, a golimumab biosimilar to Simponi® that was developed by Bio-Thera and will be marketed by STADA Launch preparations are underway to bring the second approved golimumab biosimilar to patients across Europe in the coming weeks and months...